Big Gain For Fate Therapeutics, Inc.
Mon, Dec 07, 2020 at 05:30 PM
Fate Therapeutics, Inc. (FATE:NASDAQ) soared at $83.77, representing a gain of 37.8%. On Fri 04 Dec 20, FATE:NASDAQ hit a New 2-Week High of $60.79. The stock got featured on our News Catalysts scanner on Mon 07 Dec 20 at 04:39 PM in the 'BIOTECH' category. From Fri 20 Nov 20, the stock recorded 88.89% Up Days and 90.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Fate Therapeutics, Inc. (FATE:NASDAQ)
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.
Top 10 Gainers:
- Obalon Therapeutics, Inc. (OBLN:NASDAQ), 114.95%
- Eastman Kodak Company (KODK:NYSE), 59.89%
- Gamida Cell Ltd. (GMDA:NASDAQ), 56.24%
- Oncternal Therapeutics, Inc. (ONCT:NASDAQ), 49.62%
- Greenland Technologies Holding Corporation (GTEC:NASDAQ), 49.37%
- KBNT (KBNT:NASDAQ), 43.62%
- HPK (HPK:NASDAQ), 39.6%
- Fate Therapeutics, Inc. (FATE:NASDAQ), 37.8%
- Hennessy Capital Acquisition Corp. IV (HCAC:NASDAQ), 35.32%
- EHang Holdings Limited (EH:NASDAQ), 34.87%